Skip to main content
Top

30-03-2024 | Methotrexate | Original Article

Effect of Single and Multiple Methotrexate Doses Treatment on Ovarian Reserve in Ectopic Pregnancy Women: A Prospective Cohort Study

Authors: Mahvash Zargar, Shiva ShahAli, Farideh Moramezi, Nahid Shahbazian

Published in: The Journal of Obstetrics and Gynecology of India

Login to get access

Abstract

Background

One of the main concerns for women diagnosed with ectopic pregnancy (EP). This study has been designed to evaluate the potential effects of methotrexate (MTX) single and multi-dose exposures on the ovarian reserve.

Methods

This was a prospective observational cohort study that was held in the Imam Khomeini Hospital, Ahvaz, Iran, from June 2021 to October 2022. Demographic information such as (age, body mass index (BMI), gravid, and parity) were recorded. Follicle stimulation hormone (FSH), estradiol plasma levels (on day 3 of the cycle), and Anti-Mullerian Hormone (AMH) were measured two times before MTX administration (pre-treatment) and then eight weeks after treatment (post-treatment). Also, antral follicle count (AFC) was evaluated by trans-vaginal ultrasound pre- and post-treatment.

Results

One hundred and seventy-two patients were recruited into the study. There was no difference in levels of FSH, AMH and AFC between single-dose and multiple-dose groups. There was only a statistically significant difference in estradiol levels between the two groups (P: 0.02), and estradiol concentrations were higher in the multiple-dose MTX group.

Conclusion

Administration of MTX (regardless of number of doses) has no negative effect on ovarian reserve and is safe to be used as a treatment for EP.
Literature
1.
go back to reference Sahin C, Taylan E, Akdemir A, Ozgurel B, Taskıran D, Ergenoglu AM. The impact of salpingectomy and single-dose systemic methotrexate treatments on ovarian reserve in ectopic pregnancy. Eur J Obstetr Gynecol Reprod Biol. 2016;205:150–2.CrossRef Sahin C, Taylan E, Akdemir A, Ozgurel B, Taskıran D, Ergenoglu AM. The impact of salpingectomy and single-dose systemic methotrexate treatments on ovarian reserve in ectopic pregnancy. Eur J Obstetr Gynecol Reprod Biol. 2016;205:150–2.CrossRef
2.
go back to reference Van Den Eeden SK, Shan J, Bruce C, Glasser M. Ectopic pregnancy rate and treatment utilization in a large managed care organization. Obstet Gynecol. 2005;105:1052–7.CrossRefPubMed Van Den Eeden SK, Shan J, Bruce C, Glasser M. Ectopic pregnancy rate and treatment utilization in a large managed care organization. Obstet Gynecol. 2005;105:1052–7.CrossRefPubMed
3.
go back to reference Oriol B, Barrio A, Pacheco A, Serna J, Zuzuarregui JL, Garcia-Velasco JA. Systemic methotrexate to treat ectopic pregnancy does not affect ovarian reserve. Fertil Steril. 2008;90:1579–82.CrossRefPubMed Oriol B, Barrio A, Pacheco A, Serna J, Zuzuarregui JL, Garcia-Velasco JA. Systemic methotrexate to treat ectopic pregnancy does not affect ovarian reserve. Fertil Steril. 2008;90:1579–82.CrossRefPubMed
4.
go back to reference Mullany K, Minneci M, Monjazeb R. OCC. Overview of ectopic pregnancy diagnosis, management, and innovation. Womens Health (Lond). 2023;19:17455057231160348.PubMedPubMedCentral Mullany K, Minneci M, Monjazeb R. OCC. Overview of ectopic pregnancy diagnosis, management, and innovation. Womens Health (Lond). 2023;19:17455057231160348.PubMedPubMedCentral
5.
go back to reference Taran F-A, Kagan K-O, Hübner M, Hoopmann M, Wallwiener D, Brucker S. The diagnosis and treatment of ectopic pregnancy. Dtsch Arztebl Int. 2015;112:693.PubMedPubMedCentral Taran F-A, Kagan K-O, Hübner M, Hoopmann M, Wallwiener D, Brucker S. The diagnosis and treatment of ectopic pregnancy. Dtsch Arztebl Int. 2015;112:693.PubMedPubMedCentral
6.
go back to reference Hendriks E, Rosenberg R, Prine L. Ectopic pregnancy: diagnosis and management. Am Fam Physician. 2020;101:599–606.PubMed Hendriks E, Rosenberg R, Prine L. Ectopic pregnancy: diagnosis and management. Am Fam Physician. 2020;101:599–606.PubMed
7.
go back to reference Al Naimi A, Moore P, Brüggmann D, Krysa L, Louwen F, Bahlmann F. Ectopic pregnancy: a single-center experience over ten years. Reprod Biol Endocrinol. 2021;19:1–6.CrossRef Al Naimi A, Moore P, Brüggmann D, Krysa L, Louwen F, Bahlmann F. Ectopic pregnancy: a single-center experience over ten years. Reprod Biol Endocrinol. 2021;19:1–6.CrossRef
8.
go back to reference Naveed AK, Anjum MU, Hassan A, Mahmood SN. Methotrexate versus expectant management in ectopic pregnancy: a meta-analysis. Arch Gynecol Obstetr. 2022;2022:1–7. Naveed AK, Anjum MU, Hassan A, Mahmood SN. Methotrexate versus expectant management in ectopic pregnancy: a meta-analysis. Arch Gynecol Obstetr. 2022;2022:1–7.
9.
go back to reference Zhang J, Zhang Y, Gan L, Liu X, Du S. Predictors and clinical features of methotrexate (MTX) therapy for ectopic pregnancy. BMC Pregnancy Childbirth. 2020;20:1–9.CrossRef Zhang J, Zhang Y, Gan L, Liu X, Du S. Predictors and clinical features of methotrexate (MTX) therapy for ectopic pregnancy. BMC Pregnancy Childbirth. 2020;20:1–9.CrossRef
10.
go back to reference Cohen A, Bar-On S, Cohen Y, Sandel O, Fouks Y, Michaan N, et al. Ruptured ectopic pregnancies following methotrexate treatment: clinical course and predictors for improving patient counseling. Reprod Sci. 2022;29:1209–14.CrossRefPubMed Cohen A, Bar-On S, Cohen Y, Sandel O, Fouks Y, Michaan N, et al. Ruptured ectopic pregnancies following methotrexate treatment: clinical course and predictors for improving patient counseling. Reprod Sci. 2022;29:1209–14.CrossRefPubMed
11.
go back to reference Tas M, Oner G, Ulug P, Yavuz A, Ozcelik B. Evaluation of protective effects of GnRH agonist or antagonist on ovarian reserve with anti-Müllerian hormone and histological analysis in a rat model using cisplatin. Arch Med Sci. 2023;19:448.CrossRefPubMed Tas M, Oner G, Ulug P, Yavuz A, Ozcelik B. Evaluation of protective effects of GnRH agonist or antagonist on ovarian reserve with anti-Müllerian hormone and histological analysis in a rat model using cisplatin. Arch Med Sci. 2023;19:448.CrossRefPubMed
12.
go back to reference Ahmed A, Khadija S, Irshad A. Causes of dysfunctional uterine bleeding in pre-menopausal, peri-menopausal and post-menopausal women: a systematic review of world literature between year 1992 to 2017: Causes of dysfunctional uterine bleeding. Pak BioMedical J. 2022:03-6. Ahmed A, Khadija S, Irshad A. Causes of dysfunctional uterine bleeding in pre-menopausal, peri-menopausal and post-menopausal women: a systematic review of world literature between year 1992 to 2017: Causes of dysfunctional uterine bleeding. Pak BioMedical J. 2022:03-6.
13.
go back to reference Moolhuijsen LME, Visser JA. Anti-Müllerian hormone and ovarian reserve: Update on assessing ovarian function. J Clin Endocrinol Metab. 2020;105:3361–73.CrossRefPubMedPubMedCentral Moolhuijsen LME, Visser JA. Anti-Müllerian hormone and ovarian reserve: Update on assessing ovarian function. J Clin Endocrinol Metab. 2020;105:3361–73.CrossRefPubMedPubMedCentral
14.
go back to reference Almeida F, Costermans NGJ, Soede NM, Bunschoten A, Keijer J, Kemp B, et al. Presence of anti-Müllerian hormone (AMH) during follicular development in the porcine ovary. PLoS ONE. 2018;13: e0197894.CrossRefPubMedPubMedCentral Almeida F, Costermans NGJ, Soede NM, Bunschoten A, Keijer J, Kemp B, et al. Presence of anti-Müllerian hormone (AMH) during follicular development in the porcine ovary. PLoS ONE. 2018;13: e0197894.CrossRefPubMedPubMedCentral
15.
go back to reference Vrontikis A, Chang PL, Kovacs P, Lindheim SR. Antral follice counts (AFC) predict ovarian response and pregnancy outcomes in oocyte donation cycles. J Assist Reprod Genet. 2010;27:383–9.CrossRefPubMedPubMedCentral Vrontikis A, Chang PL, Kovacs P, Lindheim SR. Antral follice counts (AFC) predict ovarian response and pregnancy outcomes in oocyte donation cycles. J Assist Reprod Genet. 2010;27:383–9.CrossRefPubMedPubMedCentral
16.
go back to reference Sinha S, Sharan A, Sinha S. Anti-Mullerian hormone as a marker of ovarian reserve and function. Cureus. 2022;14: e29214.PubMedPubMedCentral Sinha S, Sharan A, Sinha S. Anti-Mullerian hormone as a marker of ovarian reserve and function. Cureus. 2022;14: e29214.PubMedPubMedCentral
17.
go back to reference Hill MJ, Cooper JC, Levy G, Alford C, Richter KS, DeCherney AH, et al. Ovarian reserve and subsequent assisted reproduction outcomes after methotrexate therapy for ectopic pregnancy or pregnancy of unknown location. Fertil Steril. 2014;101:413–9.CrossRefPubMed Hill MJ, Cooper JC, Levy G, Alford C, Richter KS, DeCherney AH, et al. Ovarian reserve and subsequent assisted reproduction outcomes after methotrexate therapy for ectopic pregnancy or pregnancy of unknown location. Fertil Steril. 2014;101:413–9.CrossRefPubMed
18.
go back to reference Benian A, Guralp O, Uzun DD, Okyar A, Sahmay S. The effect of repeated administration of methotrexate (MTX) on rat ovary: measurement of serum antimullerian hormone (AMH) levels. Gynecol Endocrinol. 2013;29:226–9.CrossRefPubMed Benian A, Guralp O, Uzun DD, Okyar A, Sahmay S. The effect of repeated administration of methotrexate (MTX) on rat ovary: measurement of serum antimullerian hormone (AMH) levels. Gynecol Endocrinol. 2013;29:226–9.CrossRefPubMed
19.
go back to reference Ulug P, Oner G. Evaluation of the effects of single or multiple dose methotrexate administration, salpingectomy on ovarian reserve of rat with the measurement of anti-Müllerian hormone (AMH) levels and histological analysis. Eur J Obstet Gynecol Reprod Biol. 2014;181:205–9.CrossRefPubMed Ulug P, Oner G. Evaluation of the effects of single or multiple dose methotrexate administration, salpingectomy on ovarian reserve of rat with the measurement of anti-Müllerian hormone (AMH) levels and histological analysis. Eur J Obstet Gynecol Reprod Biol. 2014;181:205–9.CrossRefPubMed
20.
go back to reference Sharp SJ, Poulaliou M, Thompson SG, White IR, Wood AM. A review of published analyses of case-cohort studies and recommendations for future reporting. PLoS ONE. 2014;9: e101176.CrossRefPubMedPubMedCentral Sharp SJ, Poulaliou M, Thompson SG, White IR, Wood AM. A review of published analyses of case-cohort studies and recommendations for future reporting. PLoS ONE. 2014;9: e101176.CrossRefPubMedPubMedCentral
21.
go back to reference Shirazi M, Pooransari P, Hajiha N, Shaker Z, Ghazi M, Davari Tanha F, et al. Effect of single-dose methotrexate treatment on ovarian reserve in women with ectopic pregnancy undergoing infertility treatment: a single-center experience. Int J Fertil Steril. 2020;14:23–6.PubMedPubMedCentral Shirazi M, Pooransari P, Hajiha N, Shaker Z, Ghazi M, Davari Tanha F, et al. Effect of single-dose methotrexate treatment on ovarian reserve in women with ectopic pregnancy undergoing infertility treatment: a single-center experience. Int J Fertil Steril. 2020;14:23–6.PubMedPubMedCentral
22.
go back to reference Sahin C, Taylan E, Akdemir A, Ozgurel B, Taskıran D, Ergenoglu AM. The impact of salpingectomy and single-dose systemic methotrexate treatments on ovarian reserve in ectopic pregnancy. Eur J Obstet Gynecol Reprod Biol. 2016;205:150–2.CrossRefPubMed Sahin C, Taylan E, Akdemir A, Ozgurel B, Taskıran D, Ergenoglu AM. The impact of salpingectomy and single-dose systemic methotrexate treatments on ovarian reserve in ectopic pregnancy. Eur J Obstet Gynecol Reprod Biol. 2016;205:150–2.CrossRefPubMed
23.
go back to reference Boots CE, Gustofson RL, Feinberg EC. Does methotrexate administration for ectopic pregnancy after in vitro fertilization impact ovarian reserve or ovarian responsiveness? Fertil Steril. 2013;100:1590–3.CrossRefPubMed Boots CE, Gustofson RL, Feinberg EC. Does methotrexate administration for ectopic pregnancy after in vitro fertilization impact ovarian reserve or ovarian responsiveness? Fertil Steril. 2013;100:1590–3.CrossRefPubMed
24.
go back to reference Uyar I, Yucel OU, Gezer C, Gulhan I, Karis B, Hanhan HM, et al. Effect of single-dose methotrexate on ovarian reserve in women with ectopic pregnancy. Fertil Steril. 2013;100:1310–3.CrossRefPubMed Uyar I, Yucel OU, Gezer C, Gulhan I, Karis B, Hanhan HM, et al. Effect of single-dose methotrexate on ovarian reserve in women with ectopic pregnancy. Fertil Steril. 2013;100:1310–3.CrossRefPubMed
25.
go back to reference Mummert T, Gnugnoli DM. Ectopic Pregnancy. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2023, StatPearls Publishing LLC.; 2023. Mummert T, Gnugnoli DM. Ectopic Pregnancy. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2023, StatPearls Publishing LLC.; 2023.
26.
go back to reference ACOG Practice Bulletin No. 191: Tubal ectopic pregnancy. Obstet Gynecol. 2018;131:e65–77.CrossRef ACOG Practice Bulletin No. 191: Tubal ectopic pregnancy. Obstet Gynecol. 2018;131:e65–77.CrossRef
27.
go back to reference Çetin F, Bayramoglu Tepe N, Kutlar AI. Evaluation of the effect of multi-dose methotrexate therapy on ovarian reserve in ectopic pregnancies: is polycystic ovarian morphology a protective condition for ovarian reserve? Ginekol Pol. 2023;94:407–14.PubMed Çetin F, Bayramoglu Tepe N, Kutlar AI. Evaluation of the effect of multi-dose methotrexate therapy on ovarian reserve in ectopic pregnancies: is polycystic ovarian morphology a protective condition for ovarian reserve? Ginekol Pol. 2023;94:407–14.PubMed
28.
go back to reference Coelho Neto MA, Ludwin A, Borrell A, Benacerraf B, Dewailly D, da Silva CF, et al. Counting ovarian antral follicles by ultrasound: a practical guide. Ultrasound Obstet Gynecol. 2018;51:10–20.CrossRefPubMed Coelho Neto MA, Ludwin A, Borrell A, Benacerraf B, Dewailly D, da Silva CF, et al. Counting ovarian antral follicles by ultrasound: a practical guide. Ultrasound Obstet Gynecol. 2018;51:10–20.CrossRefPubMed
Metadata
Title
Effect of Single and Multiple Methotrexate Doses Treatment on Ovarian Reserve in Ectopic Pregnancy Women: A Prospective Cohort Study
Authors
Mahvash Zargar
Shiva ShahAli
Farideh Moramezi
Nahid Shahbazian
Publication date
30-03-2024
Publisher
Springer India
Published in
The Journal of Obstetrics and Gynecology of India
Print ISSN: 0971-9202
Electronic ISSN: 0975-6434
DOI
https://doi.org/10.1007/s13224-023-01939-5